MiMedx Group
(NASDAQ) MDXG
MiMedx Group Financials at a Glance
Market Cap
$588.34M
Revenue (TTM)
$389.42M
Net Income (TTM)
$30.70M
EPS (TTM)
$0.20
P/E Ratio
19.33
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$3.95
Volume
43,021
Open
$3.92
Price
$3.95
Volume
43,021
Open
$3.92
Previous Close
$3.95
Daily Range
$3.90 - $3.95
52-Week Range
$3.03 - $7.99
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$3.95
Volume
43,021
Open
$3.92
Previous Close
$3.95
Daily Range
$3.90 - $3.95
52-Week Range
$3.03 - $7.99
Estimated Earnings Date
Jul 29, 2026
MDXG News
MDXG: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MiMedx Group
Industry
Biotechnology
Sector
Health CareEmployees
808
CEO
Joe Capper, MBA
Website
www.mimedx.comHeadquarters
Marietta, GA 30062, US
MDXG Financials
Key Financial Metrics (TTM)
Gross Margin
81.04%
Operating Margin
10.17%
Net Income Margin
7.88%
Return on Equity
12.86%
Return on Capital
22.89%
Return on Assets
9.94%
Earnings Yield
5.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$588.34M
Shares Outstanding
148.95M
Volume
43.02K
Avg. Volume
1.57M
Financials (TTM)
Gross Profit
$315.59M
Operating Income
$39.59M
EBITDA
$57.26M
Operating Cash Flow
$70.58M
Capital Expenditure
-$5.08M
Free Cash Flow
$65.50M
Cash & ST Invst.
$159.77M
Total Debt
$17.59M
MiMedx Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$58.99M
-33.1%
Gross Profit
$41.62M
-41.9%
Gross Margin
70.56%
N/A
Market Cap
$588.34M
N/A
Market Cap/Employee
$702.91K
N/A
Employees
837
N/A
Net Income
-$10.86M
-254.6%
EBITDA
-$13.71M
-211.3%
Quarterly Fundamentals
Total Cash
$159.77M
+50.1%
Total Debt
$17.59M
-5.7%
Accounts Receivable
$46.03M
-26.1%
Inventory
$26.23M
+9.0%
Long Term Debt
$16.09M
-8.2%
Short Term Debt
$1.50M
+33.3%
Return on Assets
9.94%
N/A
Return on Invested Capital
14.99%
N/A
Free Cash Flow
$1.31M
-73.4%
Operating Cash Flow
$1.88M
-64.5%